WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Research and Development Expense
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Research and Development Expense of $22.10 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. research and development expense for the quarter ending 2011-12-31 was $9.46K, a 98.78% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. research and development expense for the quarter ending 2011-09-30 was $12.64K, a 98.68% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. research and development expense for the quarter ending 2010-12-31 was $777.22K.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. research and development expense for the quarter ending 2010-09-30 was $957.72K.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. research and development expense for fiscal 2011 was $22.10K, a 99.13% decline from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. research and development expense for fiscal 2010 was $2.54M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $9.46K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $22.10K derived: sum of 2 quarters · filed 2012-12-11 | $22.10K 10-K · filed 2012-03-30 | |
| 2011-09-30 | $12.64K 10-Q/A · filed 2012-12-11 | $12.64K 10-Q/A · filed 2012-12-11 | ||
| 2010-12-31 | $777.22K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.73M derived: sum of 2 quarters · filed 2012-03-30 | $2.47M derived: sum of 3 quarters · filed 2012-03-30 | $2.54M 10-K · filed 2012-03-30 |
| 2010-09-30 | $957.72K 10-Q · filed 2011-11-21 | $1.69M derived: sum of 2 quarters · filed 2011-11-21 | $1.76M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $732.58K 10-Q/A · filed 2011-09-01 | $802.91K 10-Q/A · filed 2011-09-01 |